Skip Nav Destination
Issues
Phase I Study of High-Dose l-Methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH Wild-Type High-Grade Glioma
Lucas A. Salas; Thomas G. Stewart; Bret C. Mobley; Chengwei Peng; Jing Liu; Sudan N. Loganathan; Jialiang Wang; Yanjun Ma; Mitchel S. Berger; Devin Absher; Yang Hu; Paul L. Moots; Brock C. Christensen; Stephen W. Clark
An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations
Deepankar Chakroborty; Veera K. Ojala; Anna M. Knittle; Jasmin Drexler; Mahlet Z. Tamirat; Regina Ruzicka; Karin Bosch; Johanna Woertl; Susanne Schmittner; Laura L. Elo; Mark S. Johnson; Kari J. Kurppa; Flavio Solca; Klaus Elenius
A Randomized Clinical Trial of Precision Prevention Materials Incorporating MC1R Genetic Risk to Improve Skin Cancer Prevention Activities Among Hispanics
John Charles A. Lacson; Scarlet H. Doyle; Jocelyn Del Rio; Stephanie M. Forgas; Rodrigo Carvajal; Guillermo Gonzalez-Calderon; Adriana Ramírez Feliciano; Youngchul Kim; Richard G. Roetzheim; Steven K. Sutton; Susan T. Vadaparampil; Brenda Soto-Torres; Peter A. Kanetsky
Association of PD-L1 Expression on Tumor and Immune Cells with Survival in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Assay Validation
Sophie Wildsmith; Jiabu Ye; April Franks; Giovanni Melillo; Jon Armstrong; Jessica Whiteley; Karina Schnittker; Fangru Lian; Bryan Roland; Constantine Sabalos; Payam Ahmadi; Jerome Fayette; Caroline Even; Ricard Mesía; Lillian L. Siu; Dan P. Zandberg; Jill Walker
Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen Selectivity
Talar Tokatlian; Grace E. Asuelime; Martin S. Naradikian; Jee-Young Mock; Mark E. Daris; Aaron D. Martin; Dora Toledo Warshaviak; Alexander Kamb; Agnes E. Hamburger
Advertisement
